Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank100
5Y CAGR+40.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+40.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive growthStable
PeriodValue
2025539.34%
2024518.93%
20230.00%
20220.00%
20210.00%
2020100.00%
2019-749.69%
2018-0.42%
20172.66%
20162.10%